Marianne P. Allen

Array ( [id] => 5017920 [patent_doc_number] => 20070261129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Nucleic acid molecules and other molecules associated with plants' [patent_app_type] => utility [patent_app_number] => 11/239625 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29111 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20070261129.pdf [firstpage_image] =>[orig_patent_app_number] => 11239625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063699 [patent_doc_number] => 20110245171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'REHYDRATION COMPOSITIONS COMPRISING EPIDERMAL GROWTH FACTOR (EGF)' [patent_app_type] => utility [patent_app_number] => 11/576303 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21257 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 85 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245171.pdf [firstpage_image] =>[orig_patent_app_number] => 11576303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251747 [patent_doc_number] => 20100028302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions' [patent_app_type] => utility [patent_app_number] => 11/663784 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26847 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028302.pdf [firstpage_image] =>[orig_patent_app_number] => 11663784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821018 [patent_doc_number] => 20060025331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Vascular endothelial growth factor 2' [patent_app_type] => utility [patent_app_number] => 11/233119 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 43358 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025331.pdf [firstpage_image] =>[orig_patent_app_number] => 11233119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132837 [patent_doc_number] => 07696170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Fibrosis inhibitor for implanted organ' [patent_app_type] => utility [patent_app_number] => 11/795314 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8587 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696170.pdf [firstpage_image] =>[orig_patent_app_number] => 11795314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4459678 [patent_doc_number] => 07879563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Method of screening for a carnitine transporter agonist or antagonist and its uses' [patent_app_type] => utility [patent_app_number] => 11/573744 [patent_app_country] => US [patent_app_date] => 2005-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 16 [patent_no_of_words] => 14365 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879563.pdf [firstpage_image] =>[orig_patent_app_number] => 11573744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613903 [patent_doc_number] => 20060115831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Map' [patent_app_type] => utility [patent_app_number] => 11/200907 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13929 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115831.pdf [firstpage_image] =>[orig_patent_app_number] => 11200907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718638 [patent_doc_number] => 20080241160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Human Monoclonal Antibodies Against Human IL-4' [patent_app_type] => utility [patent_app_number] => 11/632939 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6815 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241160.pdf [firstpage_image] =>[orig_patent_app_number] => 11632939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304102 [patent_doc_number] => 20090298754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Hai-1 and hai-2 in cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/659060 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6601 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298754.pdf [firstpage_image] =>[orig_patent_app_number] => 11659060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5155290 [patent_doc_number] => 20070038173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Methods affecting markers in patients having vascular disease' [patent_app_type] => utility [patent_app_number] => 11/190049 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9544 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20070038173.pdf [firstpage_image] =>[orig_patent_app_number] => 11190049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514762 [patent_doc_number] => 20090215069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Pancreatic polypeptide as target/marker of beta cell failure' [patent_app_type] => utility [patent_app_number] => 11/658395 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8515 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215069.pdf [firstpage_image] =>[orig_patent_app_number] => 11658395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802557 [patent_doc_number] => 20060036420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/184147 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 112414 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20060036420.pdf [firstpage_image] =>[orig_patent_app_number] => 11184147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5800342 [patent_doc_number] => 20060035329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Human hairless gene and protein' [patent_app_type] => utility [patent_app_number] => 11/182885 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17464 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035329.pdf [firstpage_image] =>[orig_patent_app_number] => 11182885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727956 [patent_doc_number] => 20080207500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Medicament' [patent_app_type] => utility [patent_app_number] => 11/631067 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7150 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207500.pdf [firstpage_image] =>[orig_patent_app_number] => 11631067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738998 [patent_doc_number] => 20060009389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use' [patent_app_type] => utility [patent_app_number] => 11/175734 [patent_app_country] => US [patent_app_date] => 2005-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7711 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009389.pdf [firstpage_image] =>[orig_patent_app_number] => 11175734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792950 [patent_doc_number] => 20080293924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Process For the Isolation and/or Purification of Proteins' [patent_app_type] => utility [patent_app_number] => 11/569393 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8632 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293924.pdf [firstpage_image] =>[orig_patent_app_number] => 11569393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125497 [patent_doc_number] => 20070237768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Fgf-21 Fusion Proteins' [patent_app_type] => utility [patent_app_number] => 11/578614 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11332 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237768.pdf [firstpage_image] =>[orig_patent_app_number] => 11578614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681815 [patent_doc_number] => 20080248041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Novel Ligands for G Protein-Coupled Receptor Protein and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/587631 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 41329 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248041.pdf [firstpage_image] =>[orig_patent_app_number] => 11587631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4475248 [patent_doc_number] => 07867973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-11 [patent_title] => 'Follistatin variant polypeptide' [patent_app_type] => utility [patent_app_number] => 11/578408 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 17815 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/867/07867973.pdf [firstpage_image] =>[orig_patent_app_number] => 11578408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069483 [patent_doc_number] => 20050244868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Ten-M3 polypeptides and polynucleotides and their methods of use' [patent_app_type] => utility [patent_app_number] => 11/096051 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26658 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244868.pdf [firstpage_image] =>[orig_patent_app_number] => 11096051 [rel_patent_id] =>[rel_patent_doc_number] =>)